Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of angiotensin iii, human, mouse tfa in China, also supports custom service. Welcome to wholesale bulk high quality angiotensin iii, human, mouse tfa from our factory. Contact us for more details.
| Description | The heptapeptide produced by N-terminal Asp removal from Ang II, acting mainly at AT2 to modulate vasodilation, renal and central sympathetic tone; TFA salt. |
Product Basic Information Table
| Standard English Name | Abbreviation/Synonym | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| Angiotensin III (human, mouse), TFA salt | Angiotensin III; Ang III; Ang(2-8); des-Asp1-angiotensin II; H-Arg-Val-Tyr-Ile-His-Pro-Phe-OH; RVYIHPF; PEP-ANG3-01 | renin-angiotensin system peptide, heptapeptide, vasoconstrictor/aldosterone-regulating peptide, AT1/AT2 receptor ligand, human-mouse homolog | A 7-residue linear angiotensin fragment, H-Arg-Val-Tyr-Ile-His-Pro-Phe-OH (RVYIHPF-OH); free N-terminal amine (Arg), C-terminal free acid (Phe-OH), no N-acetylation, no intramolecular disulfide. Residue composition: Arg×1, Val×1, Tyr×1, Ile×1, His×1, Pro×1, Phe×1; contains Tyr×1 and His×1; no Met, Trp or Cys. Cross-verified: human and mouse Ang III share the identical sequence (PubChem synonym 'Angiotensin III, human, mouse'; KEGG C15848 in the human HSA pathway). Ang III is the Ang II (DRVYIHPF-OH) fragment truncated by removing the N-terminal Asp (residues 2-8); it must be distinguished from Ang II (8-mer) and Ang(1-7) (DRVYIHP, 7-mer). Formula C46H66N12O9; recomputed mono 930.51 / avg 931.11. KEGG registers exact mass 930.5076 and MW 931.09; PubChem registers MW 931.100 and MF C46H66N12O9, external deviation <0.05 Da. Some suppliers list CAS 12687-51-3 and other registry numbers; this entry is marked no CAS per the registry. | C46H66N12O9 | 930.51 | 931.11 | TFA salt (trifluoroacetate); formula/MW are calculated on the free-peptide main chain C46H66N12O9, excluding the TFA counterion (the one-TFA salt form has an approximate MW of 1045.1, for reference only). The actual salt form and counterion stoichiometry are per lot COA. | 7 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-ANG3-01 | White to off-white powder (short peptide with one basic Arg, moderately hydrophilic; the TFA salt is hygroscopic - reseal immediately after opening, keep in a desiccator and weigh rapidly). | Store sealed, dry and light-protected at −20°C; aliquot single-use portions to avoid repeated freeze-thaw. Because it contains Tyr/His, keep light-protected to slow oxidation/degradation. As a short peptide it is not aggregation-prone; the chain has no Cys/disulfide and no Met, so there is no dedicated disulfide-cleavage or methionine-oxidation restriction. Protect the TFA salt from moisture; short-term storage at 2–8°C, dry and dark, is acceptable. | Store dry and light-protected at 2–8°C; use within 2–4 weeks; store working aliquots frozen at −20°C; ship sealed against moisture. | Short peptide, soluble in water or neutral/weakly acidic buffers. Prepare a low-concentration stock and reconstitute slowly; gentle vortexing may assist. After reconstitution: ≤1 week at 2–8°C; aliquot and freeze ≤3 months at −20°C; ≤3 freeze-thaw cycles; add 0.02% Tween-20 if needed to prevent wall adsorption; avoid pH>8; work light-protected to preserve Tyr/His residues. | Dry-sealed, stable for at least 2 years at 2–8°C; longer-term storage at −20°C; keep moisture-, light- and oxidation-protected. |
Functional Description
| Product Code | Front-end Short Summary | Detailed Biological Function | Research Areas (comma-separated) | Targets / Receptors |
| PEP-ANG3-01 | Angiotensin III (Ang III, Ang(2-8)), a 7-mer (H-Arg-Val-Tyr-Ile-His-Pro-Phe-OH), identical in human and mouse, with C-terminal free acid; free-peptide formula C46H66N12O9, MW 930.51/931.11, supplied as TFA salt. A renin-angiotensin system peptide acting via AT1/AT2 receptors to modulate vascular tone, aldosterone and vasopressin release, and central cardiovascular/fluid-electrolyte balance. | Angiotensin III (Ang III, also Ang(2-8), des-Asp1-Ang II) is generated from angiotensin II by removal of the N-terminal aspartate through aminopeptidase A (APA/EC 3.4.11.7); it is a key active heptapeptide of the renin-angiotensin system alongside Ang II. Ang III acts mainly through the G-protein-coupled AT1 and AT2 receptors: peripherally it vasoconstricts vessels, stimulates aldosterone secretion from the adrenal zona glomerulosa, promotes pituitary vasopressin release and enhances sympathetic outflow; centrally it participates in drinking behavior, blood pressure and cardiovascular reflexes, and fluid-electrolyte balance. Applications include RAS pathway and receptor pharmacology, central blood-pressure/fluid regulation, aldosterone and salt-water metabolism, and vascular remodeling models. Structure verification: the RVYIHPF-OH sequence was cross-checked against KEGG C15848, PubChem and suppliers such as CPC Scientific/TargetMol; human and mouse sequences are homologous. Formula C46H66N12O9; recomputed values match the external exact mass 930.5076 and MW 931.09–931.10 within <0.05 Da. It must be distinguished from Ang II (DRVYIHPF, 8-mer) and Ang(1-7) (DRVYIHP, 7-mer). Formula/MW are on the free-peptide main chain; the TFA counterion is excluded; salt form per COA. | renin-angiotensin system research, cardiovascular and blood-pressure regulation, aldosterone and salt-water metabolism, central neuroendocrine regulation, peptide receptor pharmacology | Angiotensin receptors AT1 and AT2 (G-protein-coupled receptors; coupled to Gq/11 and Gi-related signaling respectively); Ang III is one of their endogenous ligands. |
Hot Tags: angiotensin iii, human, mouse tfa, China angiotensin iii, human, mouse tfa manufacturers, suppliers, factory, 161748-29-4, 25696-21-3, 76461-17-1, Bradykinin 1 3 , CAS 161748 29 4, hormone peptide
